Interventional Medicine Seminar

BTG plc: Interventional Medicine Seminar

London, UK, 7 December 2017: BTG plc (LSE: BTG), the specialist healthcare company, will host an Interventional Medicine Seminar today at 10:30am at the offices of Deutsche Bank, 1 Great Winchester Street, London, EC3N 2DB.

This event will provide greater understanding of BTG's Interventional Medicine business, strategy and the people who are delivering this. No new financial information will be provided. 

For further information contact:

BTG

Andy Burrows, VP Corporate & Investor Relations

+44 (0)20 7575 1741; Mobile: +44 (0)7990 530 605

Stuart Hunt, Investor Relations Manager

+44 (0)20 7575 1582; Mobile: +44 (0)7815 778 536

Chris Sampson, Corporate Communications Director+44 (0)20 7575 1595; Mobile: +44 (0)7773 251 178

FTI Consulting

Ben Atwell/Simon Conway

+44 (0)20 3727 1000

About BTG

BTG is a global specialist healthcare company bringing to market innovative products in specialist areas of medicine to better serve doctors and their patients. We have a portfolio of Interventional Medicine products to advance the treatment of cancer, severe emphysema, severe blood clots and varicose veins, and Specialty Pharmaceuticals that help patients overexposed to certain medications or toxins. Inspired by patient and physician needs, BTG is investing to expand its portfolio to address some of today's most complex healthcare challenges. To learn more about BTG, please visit: btgplc.com.